Search

everythinglearnresearchcommunity

for

Search:↓

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

New standards were created to make chemotherapy safer and improve cancer care.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Cyclosporine combination therapy can regrow hair in severe alopecia areata but needs careful monitoring for side effects.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Shaving and applying erythromycin cream and clotrimazole powder effectively treated trichomycosis axillaris.

Imuvert can prevent some chemotherapy-induced hair loss.

L-cystine and vitamin B6 at high doses prevented hair loss in mice treated with a chemotherapy drug.

Scalp cooling is recommended to prevent chemotherapy-induced hair loss, but no effective drugs are available.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Safe treatments like minoxidil and spironolactone can help manage hair loss in breast cancer patients without increasing cancer risk.

Hair loss is a common side effect of hormone treatments for cancer.

Patients prefer non-drug methods like massage and music to manage chemotherapy side effects, but standardization is needed.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Cyclophosphamide likely causes skin darkening by affecting hair follicles.

The botanical treatment for hair loss shows promise, especially for children.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

The conclusion suggests that focusing on certain cellular pathways may improve the prevention and repair of hair loss caused by radiotherapy.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Certain cancer drugs can cause skin issues like rashes and itching.

Compound 1 showed promising anticancer activity.